DOK7-AAV IMPROVED ACETYLCHOLINE DEFICIENCY CMS IN A MOUSE MODEL AND ENHANCED THE EFFECTIVENESS OF PYRIDOSTIGMINE TREATMENT

被引：0
|
作者：
Panea, Mirela [1 ]
Webster, Richard [1 ]
Cossins, Judith [1 ]
Maxwell, Susan [1 ]
Beeson, David [1 ]
Dong, Yin Yao [1 ]
机构：
[1] Univ Oxford, Oxford, England
来源：
MUSCLE & NERVE | 2022年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S30 / S30
页数：1
相关论文
共 11 条
  • [1] Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myasthenia
    Cossins, Judith
    Kozma, Imre
    Canzonetta, Claudia
    Hawkins, Al
    Beeson, David
    Sepulveda, Patricio
    Dong, Yin Yao
    BRAIN COMMUNICATIONS, 2025, 7 (01)
  • [2] Functional characterisation of a mouse model of DOK7 congenital myasthenic syndrome and response to treatment with salbutamol
    Webster, R. G.
    Vanhaesebrouck, A. E.
    Maxwell, S. E.
    Cossins, J. A.
    Beeson, D. M. W.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S26 - S27
  • [3] Nicotinic alpha-7 acetylcholine receptor deficiency exacerbates hepatic inflammation and fibrosis in a mouse model of non-alcoholic steatohepatitis
    Kimura, Kumi
    Inaba, Yuka
    Watanabe, Hitoshi
    Matsukawa, Toshiya
    Matsumoto, Michihiro
    Inoue, Hiroshi
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (03) : 659 - 666
  • [4] SARM1 deletion delays cerebellar but not spinal cord degeneration in an enhanced mouse model of SPG7 deficiency
    Montoro-Gamez, Carolina
    Nolte, Hendrik
    Molinie, Thibaut
    Evangelista, Giovanna
    Troeder, Simon E.
    Barth, Esther
    Popovic, Milica
    Trifunovic, Aleksandra
    Zevnik, Branko
    Langer, Thomas
    Rugarli, Elena, I
    BRAIN, 2023, 146 (10) : 4117 - 4131
  • [5] Combination treatment of a PAPD5/7 inhibitor with an antisense oligonucleotide bepirovirsen with concurrent dosing shows additive HBsAg decreases in the AAV-HBV mouse model
    Delahaye, Jared
    Long, Edward
    Lau, Chi
    Parsons, Jacob
    Wen, Bo
    Cui, Zhiyi
    Paff, Melanie
    You, Shihyun
    Leivers, Martin
    JOURNAL OF HEPATOLOGY, 2022, 77 : S880 - S880
  • [6] Combination treatment of a TLR7/8 dual agonist with an antisense oligonucleotide bepirovirsen and entecavir leads to additive HBsAg decline in the AAV-HBV mouse model
    Qiu, Ke
    Deng, Zhiling
    He, Taiyu
    Chen, Zhi-Wei
    Yuan, Taichang
    Tang, Guozhi
    Peng, Ming-Li
    Ren, Hong
    JOURNAL OF HEPATOLOGY, 2024, 80 : S727 - S727
  • [7] Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model
    Leung, Joanne
    St-Onge, Philippe
    Stagg, John
    Suh, Woong-Kyung
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (04) : 491 - 502
  • [8] Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model
    Joanne Leung
    Philippe St-Onge
    John Stagg
    Woong-Kyung Suh
    Cancer Immunology, Immunotherapy, 2017, 66 : 491 - 502
  • [9] Combination treatment of a TLR7 agonist RO7020531and a capsid assembly modulator RO7049389 achieved sustainable viral loadsuppression and HBsAg loss in an AAV- HBV mouse model
    Dai, L.
    Yu, Y.
    Gu, L.
    Zhao, J.
    Zhu, L.
    Yun, H.
    Ji, Y.
    Zhu, W.
    Young, J.
    Gao, L.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S17 - S18
  • [10] Combination treatment of a TLR7 agonist RO7020531 and a capsid assembly modulator RO7049389 achieved sustainable viral load suppression and HBsAg loss in an AAV-HBV mouse model
    Gao, L.
    Dai, L.
    Yu, Y.
    Gu, L.
    Zhao, J.
    Ji, Y.
    Yun, H.
    Zhu, W.
    Young, J. A. T.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 12 - 12
12